Cyclic RGD peptide-conjugated polyplex micelles as a targetable gene delivery system directed to cells possessing alphavbeta3 and alphavbeta5 integrins.
about
The Role of Cell-Penetrating Peptide and Transferrin on Enhanced Delivery of Drug to BrainThe potential of polymeric micelles in the context of glioblastoma therapy.Density-tunable conjugation of cyclic RGD ligands with polyion complex vesicles for the neovascular imaging of orthotopic glioblastomasGene delivery mediated by recombinant silk proteins containing cationic and cell binding motifs.Antheraea pernyi silk fibroin-coated PEI/DNA complexes for targeted gene delivery in HEK 293 and HCT 116 cellsEnhancement of cellular uptake and antitumor efficiencies of micelles with phosphorylcholine.Targeted gene silencing using RGD-labeled chitosan nanoparticles.Encapsidated atom-transfer radical polymerization in Qβ virus-like nanoparticlesA cyclic-RGD-BioShuttle functionalized with TMZ by DARinv "Click Chemistry" targeted to αvβ3 integrin for therapy.Assay for characterizing the recovery of vertebrate cells for adhesion measurements by single-cell force spectroscopy.EILDV-conjugated, etoposide-loaded biodegradable polymeric micelles directing to tumor metastatic cells overexpressing α4β1 integrinThe Protein Corona of Plant Virus Nanoparticles Influences their Dispersion Properties, Cellular Interactions, and In Vivo Fates.α(V)β(3) integrin-targeted PLGA-PEG nanoparticles for enhanced anti-tumor efficacy of a Pt(IV) prodrugSystemic Administration of siRNA via cRGD-containing Peptide.The effect of nanoparticle polyethylene glycol surface density on ligand-directed tumor targeting studied in vivo by dual modality imaging.Cyclic RGD-targeting of reversibly stabilized DNA nanoparticles enhances cell uptake and transfection in vitro.Polymeric micelles from poly(ethylene glycol)-poly(amino acid) block copolymer for drug and gene deliveryCombinatorial nanocarrier based drug delivery approach for amalgamation of anti-tumor agents in bresat cancer cells: an improved nanomedicine strategies.Peptide- and aptamer-functionalized nanovectors for targeted delivery of therapeutics.Silk-based delivery systems of bioactive molecules.New short interfering RNA-based therapies for glomerulonephritis.Rational design of smart supramolecular assemblies for gene delivery: chemical challenges in the creation of artificial viruses.A review of RGD-functionalized nonviral gene delivery vectors for cancer therapy.Stimuli-sensitive synthetic polypeptide-based materials for drug and gene delivery.Tumor Targeting via Integrin Ligands.Polymeric nano-micelles: versatile platform for targeted delivery in cancer.Dependence of cancer cell adhesion kinetics on integrin ligand surface density measured by a high-throughput label-free resonant waveguide grating biosensorStudy of the selective uptake progress of aptamer-modified PLGA particles by liver cells.An epidermal growth factor motif from Del1 protein increases the efficiency of in vivo gene transfer with a non-viral vector.Solid-phase-assisted synthesis of targeting peptide-PEG-oligo(ethane amino)amides for receptor-mediated gene delivery.Bioreducible polyether-based pDNA ternary polyplexes: balancing particle stability and transfection efficiency.Pluronic-based cationic block copolymer for forming pDNA polyplexes with enhanced cellular uptake and improved transfection efficiency.Triblock copolymer-encapsulated nanoparticles with outstanding colloidal stability for siRNA delivery.Effect of integrin receptor-targeted liposomal paclitaxel for hepatocellular carcinoma targeting and therapy.Anti-tumor effect of RGD modified PTX loaded liposome on prostatic cancer.Impact of polyplex micelles installed with cyclic RGD peptide as ligand on gene delivery to vascular lesions.A versatile multicomponent assembly via β-cyclodextrin host-guest chemistry on graphene for biomedical applications.Multilayered polyion complexes with dissolvable silica layer covered by controlling densities of cRGD-conjugated PEG chains for cancer-targeted siRNA delivery.Influence of short-chain cell-penetrating peptides on transport of doxorubicin encapsulating receptor-targeted liposomes across brain endothelial barrier.MSN-mediated sequential vascular-to-cell nuclear-targeted drug delivery for efficient tumor regression.
P2860
Q26745586-0A90EA83-C5DF-46E0-8A3F-7413E44FDA79Q27693205-1993DD46-E9F8-4E01-9BF4-32E1EC491FA6Q31144211-E0AECA27-ABA3-4F8B-A5ED-D5BFB47291BBQ33574252-F1C49DA3-94A7-4F6B-8F79-689891AD3F0CQ33755498-F36CAD12-90FC-4BC4-9B24-45B82C7AF085Q33972760-939C8A98-EE18-4F81-AAB1-68D15B575658Q34031859-C4EEBDAC-493D-4925-B35E-C60FA8D6E87EQ34104230-13DF4852-CE09-4DF2-9F36-0C229CE6B1D7Q34167014-19857D14-BF98-4BC3-B289-B697F208A504Q35188067-5E004DA5-ADE5-43CF-BCC6-78C08C04F814Q35673648-1ACF0CDC-BDAE-4480-ACD5-7B0FA69B36A4Q35917005-3EDE1776-0ABB-4A70-B2A7-8F6C118A164FQ35981228-7B71DC87-7D49-4AF6-9E20-E6E835757DDAQ35989535-701CF32B-9FB8-4B70-BA6A-8B391D83A070Q36075868-A772D211-109F-4D18-A6CC-D4549C525821Q36306814-871E56DF-2993-4BA3-8D18-417598B307B8Q37211504-016AA4AF-86BA-48D3-A66A-9AA31F740BDBQ37325256-CB48CCB2-EBA3-45F0-8337-CB6E3D90DA69Q37572760-5D384CFF-535C-4C40-9920-F5ADBD1DD96EQ37714025-7FA623DF-2568-4B67-8FD4-C73194C1F2B9Q37879444-BAD7A886-8E9C-4CAD-9F67-44AC33F35C7AQ37959311-8AB6226E-130B-47EA-9B26-88F8F69ED62DQ38047231-CD0D0E7B-0EB9-43C4-AFD5-01D00B387270Q38062891-4503F2CD-4BFD-4D73-B774-9B75B39D9C88Q38134759-5F21B8B5-96C2-433A-9CCC-BD7A1A08ABE4Q38270690-2434566A-3C88-46C4-A34A-CC7A254819C2Q39026452-31B5062B-4A4E-4F80-AA05-8F50416A2FCAQ39123634-15C85F69-4FE0-45E0-9BC2-23FBB19B81BBQ39316762-641F16CE-4081-4E05-8155-6C82695538DAQ39381829-D64AECB3-C348-438F-B6AF-EA0D01973617Q39458012-794916E4-A48F-4A88-8FD1-2D32468FBAADQ39567567-180D47FD-2054-4DDF-9F8F-C78986E6BDFBQ40107465-512A0F85-4524-44AB-A130-3B8AC97AE240Q41110002-B671D51F-BD56-4BD9-8B7E-3375859B6807Q41880095-C6FBB899-7581-412E-BAAE-6D2052219FFEQ45870761-A3BF36A1-5030-46D9-A041-3D1FF4CBCD4EQ46839203-9D00684F-F917-41EC-912B-7808EBD2FF85Q48144871-55C42D8A-C496-4ED1-9F04-25088116B4DEQ48867737-04E8F923-9D00-4A21-88E2-4FB9132AC7F5Q51060665-7823F992-8DB1-4E8E-A0A8-6DD060DD8DC6
P2860
Cyclic RGD peptide-conjugated polyplex micelles as a targetable gene delivery system directed to cells possessing alphavbeta3 and alphavbeta5 integrins.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Cyclic RGD peptide-conjugated ...... ta3 and alphavbeta5 integrins.
@ast
Cyclic RGD peptide-conjugated ...... ta3 and alphavbeta5 integrins.
@en
Cyclic RGD peptide-conjugated ...... ta3 and alphavbeta5 integrins.
@nl
type
label
Cyclic RGD peptide-conjugated ...... ta3 and alphavbeta5 integrins.
@ast
Cyclic RGD peptide-conjugated ...... ta3 and alphavbeta5 integrins.
@en
Cyclic RGD peptide-conjugated ...... ta3 and alphavbeta5 integrins.
@nl
prefLabel
Cyclic RGD peptide-conjugated ...... ta3 and alphavbeta5 integrins.
@ast
Cyclic RGD peptide-conjugated ...... ta3 and alphavbeta5 integrins.
@en
Cyclic RGD peptide-conjugated ...... ta3 and alphavbeta5 integrins.
@nl
P2093
P356
P1476
Cyclic RGD peptide-conjugated ...... ta3 and alphavbeta5 integrins.
@en
P2093
Hiroyuki Koyama
Kazuhiro Aoyagi
Kazunori Kataoka
Naoki Kanayama
Nobuhiro Nishiyama
Shigeto Fukushima
P304
P356
10.1021/BC0700133
P50
P577
2007-06-27T00:00:00Z